CURLF

$10.14+10.70%visit website

Curaleaf Holdings, Inc.

Market Cap

$2.4B

Live price × Finnhub shares (2026-09-18)

Sector

Health Care

Industry

Pharmaceuticals

Beta (raw)

1.62

60mo monthly vs SPY

P/E (TTM)

—

Price / TTM diluted EPS

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

—

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Jun 2025 Jun 30, 2025	Sep 2025 Sep 30, 2025	Q2 FY2026 Jun 30, 2026	Q3 FY2026 Sep 30, 2026
Revenue	310,586	317,856	340,099	352,650
Cost of revenue	157,502	157,279	170,185	182,173
Gross profit	153,084	160,577	169,914	170,477
Selling, general & administrative	111,357	118,512	131,677	131,027
Total operating expenses	146,838	153,655	165,692	167,534
Operating income	6,246	6,922	4,222	2,943
Interest expense	13,673	13,575
Pretax income	(16,270)	(21,417)	(26,308)	(22,855)
Income tax	31,841	32,833	(38,784)	14,509
Net income	(53,161)	(57,029)	12,507	(32,721)
EPS (basic) ($)	(0.26)	(0.25)	0.05	(0.12)
EPS (diluted) ($)	(0.26)	(0.25)	0.05	(0.12)
Weighted avg. shares (basic)	252,424	254,942	263,068	264,883
Weighted avg. shares (diluted)	252,424	254,942	270,702	264,883

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Nov 3, 2026, period ended Sep 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Corporate Events (8-K)

3 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Nov 3, 2026 accepted 4:02 PM ET	2.02Earnings release	Document SEC ↗
Nov 3, 2026 accepted 6:02 PM ET	7.01Reg FD disclosure	Document SEC ↗
Oct 28, 2026 accepted 2:59 PM ET	8.01Other events	Document SEC ↗